UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Ways To Identify Budgeting Challenges
Identifying budgeting challenges helps you target improvements. This guide outlines practical methods to pinpoint where your budget struggles.
11,304 articles
Kickstarter’s Stands 4-Day Workweek Amid CEO Debate
Kickstarter’s stands 4-day workweek, a bold move for a remote-first company. The CEO says it balances life with high ...
Down 70%, Should Rigetti Buy the Dip Right Now?
Rigetti Computing has dropped about 70% from its 52-week high. This article breaks down whether the dip offers real u...
Bitcoin’s 12-Year Link to the Dollar Breaks This Week
Bitcoin staged a striking break from a long-standing pattern, defying a rising dollar as ETF inflows surged. Analysts...
Finally, Little Good News for Lucid Investors This Year
Lucid delivered higher volumes and nudged toward improving efficiency, signaling a potential turn in its long EV jour...
Blend Labs CEO Says I Am Excited Amid Stock Slump
Blend Labs reports a split quarter: Consumer Banking grows while Mortgage slows, as the stock slides about 46% over t...
Garden Investment Adds Large Stake in Middleby Ahead SpinOff
A major family-office investor has increased its position in Middleby as the company prepares a spin-off. This move o...
Infinity Natural (INR) Earnings: A Practical Guide
Discover how to read Infinity Natural's earnings calls like a pro. This guide explains the metrics to watch, how mana...
Mission Produce (AVO) 2026 Outlook: Early Q1 Takeaways
Mission Produce enters 2026 with a mix of hedges, growing demand, and a tight supply chain. This guide breaks down wh...
China’s Power ‘Supergrid’ Gives Buffers Against Shocks
China accelerates grid expansion to channel renewables and cut imports, a move shaping energy costs and bond markets ...
Polymarket Bettors Send Death Threats Over Missile Report
A reporter documenting a geopolitics-driven forecast market linked to a $14 million pool received direct threats, pro...
Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status